IDF Innov-allied brain implant developer Neurallys plans to market sensors that measure intracranial pressure to combat the severe neurological complication hydrocephalus.
Neurallys, a France-based brain implant developer founded with support from regional tech transfer office Satt IDF Innov, today completed a €750,000 ($850,000) round backed by Doliam Group and HAC Futur.
Both investors are registered as companies in France, however further details could not be ascertained.
Founded in 2016, Neurallys has created a sensor-equipped brain implant that measures and records pressure within the skull.
The device is intended to help clinicians monitor hydrocephalus, a severe neurological complication caused as cerebrospinal fluid accumulates in the brain that can result from conditions such as rupture aneurysm, stroke and brain tumours.
The fresh injection of capital will go towards recruiting three additional engineers to support Neurallys’ R&D plans. Proceeds from the round will also help it complete a prototype of its implant for preclinical testing.
Neurallys’s management includes chief technology officer Lionel Rousseau, a doctor focused on microelectronics at engineering graduate school ESIEE Paris, and Philippe Cornu, head of neurosurgery at the Pitié-Salpêtrière teaching hospital.
